With four manufacturing sites, continuous personnel growth, and long-term experience in Quality beginning in 1964 with our first FDA inspection, FIS has built experience through the development and manufacture of over 400 different intermediates and APIs.
Multiple Sites
Montecchio Maggiore Site (Headquarters)
  • 1750m3 production capacity
  • Segregated plant for antibiotics (except β-lactam) and steroids (up to OEB4)
  • Dedicated plants for oncologics, high-potency APIs, psychotropics
  • Sterile
  • Spray drying
  • Fluorination
Lonigo Site
  • 650m3 production capacity
  • Dedicated plant for antibiotics (except β-lactam) and high-potency products
Termoli Site
  • 650 m3 production capacity
Delmar Montreal site
  • 415-615m3 production capacity
Multiple technology platform
  • Organometallic reactions
  • High-pressure hydrogenation up to 40bar
  • Reductions Palladium-catalyzed coupling reactions
  • Cryogenic chemistry (-80°C and below)
  • Enantioselective synthesis
  • Phosgenation via diphosgene generated in-house
  • Biocatalytic processes
  • Lyophilization
  • Spray drying
  • Sterile
  • Fluorination chemistry
  • Flow chemistry